ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 412

Single Nucleotide Polymorphisms within the HLA-DRB1 Gene in Relation to Antibodies Against Citrullinated Peptides in Individuals Prior to the Development of Rheumatoid Arthritis

Lisbeth Arlestig1, Mikael Brink2, Monika Hansson3, Per Johan Jakobsson4, Rikard Holmdahl5, Linda Mathsson6, Johan Ronnelid6, Lars Klareskog7 and Solbritt M. Rantapaa-Dahlqvist8, 1Rheumatology, Umeå University, Umea, Sweden, 2Umea University, Umea, Sweden, 3Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 4Rheumatology unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 5Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden, 6Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden, 7Department of Medicine, Rheumatology Unit, Karolinska Institute, Stockholm, Sweden, 8Rheumatology, Institution of Public health and clinical medicine/ Rheumatology, University of Umeå, Umeå, Sweden, Umea, Sweden

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: anti-CCP antibodies, citrullinated vimentin, human leukocyte antigens (HLA) and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenisis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Multiplex analysis has demonstrated the presence of several antibodies against cyclic citrullinated peptides (ACPA) preceding the development of rheumatoid arthritis (RA) by several years. Certain HLA-DRB1* alleles are strongly associated with RA.

To relate the presence of different ACPAs, in individuals before the onset of symptoms of RA, to single nucleotide polymorphisms (SNPs) within the HLA-DRB1 region in order to identify the SNPs most highly associated  with the ACPAs analysed in the disease development.

Methods:

The study group comprised 406 individuals, with 717 samples, who were identified before the onset of symptoms (median (IQR) 7.4 (9.3) years), as donors to the Medical Biobank of Northern Sweden. A total of 976 population controls were identified from the Medical Biobank for analysis of antibodies against 10 different citrullinated peptides in plasma using a microarray system developed in collaboration withPhadia AB/Thermofisher, Uppsala, based on their ISAC platform. In a previous study the highest frequencies of antibodies were found for fibrinogen (Fib) ß36‑52, α-enolase (CEP-1), and filaggrin. Anti-CCP2 antibodies were analysed using ELISA (Euro-Diagnostics). Samples from the same individuals were genotyped with the Immunochip custom array according to Illumina protocols (SNP&SEQ Technology Platform, Uppsala, Sweden). 81 SNPs covering the HLA-DRB1* to DQA1* region were analysed. The Haploview software version 4.2 was used for haplotype and association analysis with a permutation test.

Results:

Thirty-seven of the SNPs were associated with the pre-diseased individuals compared with controls. After permutation test 22 of them and six haplotypes (7-16 SNPs) remained significantly associated. Anti-CEP-1 antibodies were associated with 15 SNPs although none remained significant after permutation tests. Anti-filaggrin antibodies were related to 4 SNPs, two of which were similar as for anti-CEP-1 (rs9271588 and rs9272363), none remained significant after permutation test. Anti-Fibß36-52 antibodies were associated with 4 different SNPs compared with the other antibodies and none were significant after permutation test. Of the SNPs analysed 21 were associated with anti-CCP2 antibodies and two of them (rs9271588, rs9271850) and three haplotypes were significantly associated after a permutation test.

Conclusion:

The presence of ACPAs is related to a number of SNPs within the HLA- region albeit with somewhat different patterns between the various antibodies.


Disclosure:

L. Arlestig,
None;

M. Brink,
None;

M. Hansson,
None;

P. J. Jakobsson,
None;

R. Holmdahl,
None;

L. Mathsson,
None;

J. Ronnelid,
None;

L. Klareskog,
None;

S. M. Rantapaa-Dahlqvist,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-nucleotide-polymorphisms-within-the-hla-drb1-gene-in-relation-to-antibodies-against-citrullinated-peptides-in-individuals-prior-to-the-development-of-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology